{"name":"Jordan Feld","slug":"jordan-feld","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQN3F3dllraHpyenoyY0w0YXdBcXlMczNIaExkRDI0YUVRQ0ZxbVlkVlNVVVdhb3AyUjh0U0dtemItM09CSHlZUDlyWk51ejNHZ05vSGFTN01tSDFVLWFPR2NsME00YVRhN1hBOFdQQUJibWc3dUVDaGE5VjBmVUY2a2ZUaVJJbmVnTnZYa0xmaDNoS3M3UWNBQUU5YWhKWTNMT2xXdHVVTWs1TnJP?oc=5","date":"2025-06-25","type":"deal","source":"The Business Journals","summary":"Arbutus terminates potential $285M licensing deal with Chinese drug company - The Business Journals","headline":"Arbutus terminates potential $285M licensing deal with Chinese drug company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAJBVV95cUxObW44LXlJQ1MzLWJjeGRhQ25rVnRBMmp5T3lxUEFqY0IyTWViSkJ0NXNWbm9MT1VQcWFTcEp4V3NhVGlNNlAtNF9RT0pUZjYzZU9WclBRRDBpX0l0aGVHamJRT20wZWJ0ZDNIcF9BZ0dXYmtGOUVwb3JfTUJCWWFHREpwbDhjRlVaNlFYNGVWV2h0aEpvcThGQWQtc21FRTFKVE8tNGN5aHlWamJUbW5oa2JaTXF6VzhCRnJFdkZxYW5tUGEyOFpCQVRUZi11NmRUYzV1VDhSX24zRzBWcm56LXJzaVdBTGpzUmp0S3dHcGZnWEx5dXdXN1ZDTDFRa24yOXplM0xhZ19jTmVMNXpPY2tnTkRPbURXMnd2cmhSV0lyTDdfdWoyLQ?oc=5","date":"2025-06-25","type":"deal","source":"GlobeNewswire","summary":"Arbutus Reacquires Greater China Rights to Imdusiran and - GlobeNewswire","headline":"Arbutus Reacquires Greater China Rights to Imdusiran and","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPdzhoTjBWNHlFbkFlcjZzOFZKaGxhaUFYYUdZMmJWV2RBS2ZuNHdZSzA2UG5mblRSRXNRQlB0dHpyTHo4aHFhQUZ4QkdSNm82V1lZbTFkOFBFMHVMcnhLT2VLRGFOZXEtWXdTXzFGZDMwM3prSnN3ZkJZZGpvSVNneU91QUhueEdxTHNVaHVjZEh4LXN1eThzaTUzWWNrUXJiZm1EZmRIVzF4aTdCcko5Rmtidm1ybWJwTDdEMw?oc=5","date":"2021-02-08","type":"trial","source":"European Pharmaceutical Review","summary":"Peginterferon-lambda accelerates COVID-19 recovery, finds trial - European Pharmaceutical Review","headline":"Peginterferon-lambda accelerates COVID-19 recovery, finds trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1TUEUxYlg2aTBTOUdpaldfandhQmctNy0wc1FDenZYa2RseXJySWZuOUJSQUNXVy1leVBBUDJFazBfZ0dMSERDbi1lbHlKMlFBdUVZSDBXYUVZZi04STNz?oc=5","date":"2018-06-27","type":"pipeline","source":"NEJM","summary":"Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin - NEJM","headline":"Treatment of HCV with ABT-450/r–Ombitasvir and Dasabuvir with Ribavirin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTE9JdUFzYnlWQTdUTEZ2Q3RMOWlJTkFuY0RKX0NHbS1PaDdZTFR1WWxodHQ1YzRMcnQxeDEzc0V3WjNGRTRuMGlKNktQVjhTYTd3Z2w0NEVrR0dkUQ?oc=5","date":"2016-12-02","type":"pipeline","source":"Healthy Debate","summary":"Should markups on high-cost drugs be capped? - Healthy Debate","headline":"Should markups on high-cost drugs be capped?","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}